"Michigan State University Neurology and Ophthalmology specializes in the diagnosis and treatment of all types of disease or impaired function of the brain, spinal cord, peripheral nerves, muscles, and autonomic nervous system, as well as the blood vessels that relate to these structures. Our providers hold faculty appointments within Michigan State University⿿s College of Osteopathic Medicine or the College of Human Medicine Department of Neurology. We treat newborns through geriatric patients at MSU Clinical Center. We offer several specialized clinics to treat many different types of neurological and ophthalmologic disorders and diseases from cognitive disorders like Alzheimer's and Dementia to Vascular conditions like strokes."

During the past decade, Michigan State University Department of Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michigan State University Department of Neurology" #1 sponsor was "Biogen" with 1 trials, followed by "Celgene" with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored, "Neurocrine Biosciences" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michigan State University Department of Neurology" #1 collaborator was "Elan Pharmaceuticals" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "University of California, Davis" with 1 trials as a collaborator, "University of Iowa" with 1 trials as a collaborator and "University of Rochester" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Michigan State University Department of Neurology" are "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials), "Idiopathic Intracranial Hypertension" (1 trials) and "Parkinson's Disease" (1 trials). Many other conditions were trialed in "Michigan State University Department of Neurology" in a lesser frequency.

Most popular intervention types in "Michigan State University Department of Neurology" are "Drug" (5 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AVP-786" (1 trials), "Acetazolamide" (1 trials), "Droxidopa capsules" (1 trials) and "Fingolimod" (1 trials). Other intervention names were less common.

The vast majority of trials in "Michigan State University Department of Neurology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Michigan State University Department of Neurology". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Michigan State University Department of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michigan State University Department of Neurology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".